A detailed history of Simplex Trading, LLC transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Simplex Trading, LLC holds 726 shares of SLGL stock, worth $515. This represents 0.0% of its overall portfolio holdings.

Number of Shares
726
Previous 526 38.02%
Holding current value
$515
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$0.66 - $1.05 $132 - $210
200 Added 38.02%
726 $0
Q1 2024

Apr 25, 2024

BUY
$0.95 - $1.5 $499 - $789
526 New
526 $0
Q1 2023

Apr 27, 2023

BUY
$3.44 - $5.32 $1,506 - $2,330
438 Added 202.78%
654 $2,000
Q4 2022

Feb 02, 2023

BUY
$4.26 - $5.22 $920 - $1,127
216 New
216 $0
Q2 2022

Aug 03, 2022

SELL
$4.1 - $7.36 $9,721 - $17,450
-2,371 Reduced 91.72%
214 $0
Q1 2022

May 02, 2022

BUY
$6.64 - $8.21 $10,424 - $12,889
1,570 Added 154.68%
2,585 $19,000
Q4 2021

Feb 23, 2022

BUY
$6.57 - $9.78 $6,668 - $9,926
1,015 New
1,015 $7,000

Others Institutions Holding SLGL

About Sol-Gel Technologies Ltd.


  • Ticker SLGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,129,500
  • Market Cap $16.4M
  • Description
  • Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...
More about SLGL
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.